pharma Generic drug price-fixing: South Dakota’s Smart Settlement October 11, 2026 Kenneth Bennett Generic drug price-fixing has led South Dakota to join settlements aimed at lowering costs.
pharma Korea obesity drug: Clear Approval for Proven Treatment October 8, 2026 Kenneth Bennett Korea obesity drug has received approval, promising a proven solution for weight management. Launch set for October.
pharma Brinzolamide Ophthalmic API: The Best Launch from C2 Pharma October 3, 2026 Kenneth Bennett Brinzolamide ophthalmic API is now available from C2 Pharma, offering proven solutions for eye care.
pharma Ono Pharmaceutical Excopri Approval: A Clear Positive Change September 26, 2026 Kenneth Bennett Ono Pharmaceutical Excopri approval could change the company's narrative significantly.
pharma Oncology portfolio approvals: Proven benefits for patients September 22, 2026 Kenneth Bennett Oncology portfolio approvals are crucial for advancing treatment options in Azerbaijan.
pharma Eli Lilly FDA approvals: Are They the Right Growth Strategy? September 9, 2026 Kenneth Bennett Eli Lilly FDA approvals could be a game changer for growth. Discover the potential impact on the company's future.
pharma Neurotech cannabinoid approval: A Clear Path to Success September 9, 2026 Kenneth Bennett Neurotech cannabinoid approval could lead to significant advancements in the pharmaceutical industry. Discover the potential impact now.
